Suppr超能文献

钙调蛋白拮抗剂对培养细胞抗增殖作用的比较研究——具有改善细胞生长抑制潜力的W7衍生物

A comparative study of the anti-proliferative effects of calmodulin antagonists in cultured cells--W7 derivatives of improved cytostatic potential.

作者信息

Barton C H, Blackburn G M, Rees R, Bleehen S S, Senior J H, Munro D S, MacNeil S

出版信息

Carcinogenesis. 1987 Jul;8(7):919-23. doi: 10.1093/carcin/8.7.919.

Abstract

We have compared the effects of the calmodulin antagonist N-(6-aminohexyl)-5-chloro-1-naphthalene-sulphonamide (W7) and relatives of the parent compound, modified by substituting the 5-chloro- for an iodo-residue and increasing stepwise the length of the carbon chain from 6 to 12, for their ability to inhibit cell proliferation in tissue culture. These species showed improved specificity and potency, as determined against a calcium calmodulin-dependent beef heart phosphodiesterase in vitro, exhibited time courses of inhibition similar to the parent compound W7, but were more potent at inhibiting DNA synthesis in K562 human leukaemic cells cultured in serum-free medium. The elevation observed in the percentage of cells in G1 of the cell cycle following drug exposure indicated that these drugs, like W7, arrested growth by inhibiting entry of cells into and through S phase. Higher doses of all drugs were irreversibly cytotoxic as determined by the inability of the cells to recover DNA synthetic capacity and to form colonies in soft agar or to recover their normal cell cycle distribution. We also discuss the possible implications of extracellular calmodulin and antagonism thereof on cell proliferation.

摘要

我们比较了钙调蛋白拮抗剂N-(6-氨基己基)-5-氯-1-萘磺酰胺(W7)及其母体化合物的衍生物(用碘取代5-氯,并逐步将碳链长度从6增加到12)在组织培养中抑制细胞增殖的能力。这些衍生物表现出更高的特异性和效力,体外针对钙调蛋白依赖性牛心磷酸二酯酶测定时,其抑制时间进程与母体化合物W7相似,但在抑制无血清培养基中培养的K562人白血病细胞的DNA合成方面更有效。药物处理后,细胞周期G1期细胞百分比升高,表明这些药物与W7一样,通过抑制细胞进入和通过S期来阻止生长。通过细胞无法恢复DNA合成能力、在软琼脂中形成集落或恢复其正常细胞周期分布来确定,所有药物的高剂量均具有不可逆的细胞毒性。我们还讨论了细胞外钙调蛋白及其拮抗剂对细胞增殖的可能影响。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验